AprilBio Co.,Ltd. (397030.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩12,340 (-0.48%) as of
Key statistics
- Market cap
- 288.93B
- Forward P/E
- -12.92
- Dividend yield
- 0.00%
- 52-week range
- 11,810.00 – 76,700.00
- Beta
- 1.61
- Revenue (TTM)
- 725.35M
- Profit margin
- 0.00%
- Analyst target
- ₩100,000
- Volume
- 85.99k
About AprilBio Co.,Ltd.
AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Chuncheon-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.